Analysis of semi-volatile organic compounds in exhaled breath condensate of patients with obstructive lung diseases

E. Anaev, T. Anokhina, A. Rodionov, A. Revelsky, I. Revelsky, D. Alexeev, V. Kudriavtsev, A. Chuchalin (Moscow, Russian Federation)

Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Session: COPD: systemic inflammation and comorbidities
Session type: Thematic Poster Session
Number: 558
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Anaev, T. Anokhina, A. Rodionov, A. Revelsky, I. Revelsky, D. Alexeev, V. Kudriavtsev, A. Chuchalin (Moscow, Russian Federation). Analysis of semi-volatile organic compounds in exhaled breath condensate of patients with obstructive lung diseases. Eur Respir J 2010; 36: Suppl. 54, 558

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Volatile organic compounds (VOC) in exhaled breath of patients with COPD
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases
Year: 2010

Semi-volatile organic compounds in exhaled breath condensate: a new approach in the differential diagnosis of asthma and COPD
Source: Annual Congress 2009 - Asthma assessment and original therapeutic approaches
Year: 2009


Structures of an exhaled breath condensate in lung diseases
Source: Eur Respir J 2005; 26: Suppl. 49, 525s
Year: 2005

Volatile organic compounds in exhaled breath are associated with exacerbations in children with asthma
Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma
Year: 2009

Metabolomic analysis of exhaled breath condensate in diagnostics of obstructive airway diseases
Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Year: 2011

Value of exhaled volatile organic compounds in monitoring airway disease
Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases
Year: 2013


Exhaled breath condensate biomarkers in COPD
Source: Eur Respir J 2008; 32: 472-486
Year: 2008



Volatile organic compounds (VOCs) in exhaled air of patients with lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 208s
Year: 2003

Reproducibility of exhaled breath condensate pH in chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 25: 269-274
Year: 2005



Volatile organic compounds (VOC) in exhaled breath in patients with lung cancer, using the analytical technique thermal desorber- gase chromatography-spectrometer mases
Source: Annual Congress 2012 - New biomarkers for lung cancer
Year: 2012


The pH-value of exhaled breath condensate - mainly influenced by exhaled volatile compounds
Source: Eur Respir J 2005; 26: Suppl. 49, 373s
Year: 2005